Eton Pharmaceutcials, Inc. Common Stock vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ETON | JNJ | |
|---|---|---|
| Market Cap | $1.68 billion | $627.42 billion |
| Revenue (TTM) | $105.59 million | $97.93 billion |
| Net Income (TTM) | $12.69 million | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| ETON | JNJ | |
|---|---|---|
| P/E Ratio | — | 30.44 |
| Price / Book | 36.11 | 7.38 |
| Price / Sales | 15.93 | 6.41 |
JNJ leads on 2 of 2 valuation factors.
Profitability
| ETON | JNJ | |
|---|---|---|
| Net Margin | 12.02% | 21.48% |
| Return on Equity | 27.24% | 24.76% |
ETON and JNJ split the profitability factors evenly.
Dividend
| ETON | JNJ | |
|---|---|---|
| Dividend Yield | — | 2.04% |
| Payout Ratio | — | 62.18 |
ETON and JNJ split the dividend factors evenly.
Risk & Sentiment
| ETON | JNJ | |
|---|---|---|
| Short Interest | 0.21% | 0.67% |
ETON leads on 1 of 1 risk & sentiment factors.
Dig deeper: ETON overview, ETON financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
